Download Longevity & Mortality Investor Volume 2, Issue 4, April 2026

Two recent litigation cases relating to whether term life insurance policy conversions retain their original insurable interest produced opposite results for the life settlement market. Greg Winterton covers both, and spoke to Bryan Nicholson, Executive Director at LISA, and Rob Haynie, Managing Director at Life Insurance Settlements (and current LISA Chair) to get their thoughts on one, in Life Settlement Market Faces Contrasting Views on Term Life Policy Conversions. 

Multi-cancer early detection (MCED) tests offer significant potential to impact mortality curves, but the technology is still in its infancy. Mark McCord speaks with Dr. Steven Rigatti, Founder of Rigatti Risk Analytics, to discuss whether current data warrants a shift in actuarial thinking in Pricing in the Unknown: Why Mortality Models Aren’t Ready for MCED Tests Just Yet. 

The US pension risk transfer market recovered from a slow start to deliver yet another strong year of aggregate premium. The main story in the space, however, is the increasing activity in buy-in transactions. Greg Winterton gathered thoughts on the topic from Alex Gagnon, Vice President and Head of Distribution at insurer Banner Life and Keith Golembiewski, Assistant Vice President and Head of LIMRA Annuity Research in Emergence of Buy-In Deals Supports Third Biggest Year on Record for US Pension Risk Transfer Market. 

This year’s update to the Continuous Mortality Investigation’s model is expected to increase defined benefit pension scheme liabilities by 0.5% for schemes that adopt the model in place of last year’s. Greg Winterton collected insights from Alan Greenlees, Professional Trustee at ZEDRA and WTW’s Stephen Caine, Head of Mortality and Gemma Millington, Senior Pensions Risk Transfer Director to find out what the impact on the de-risking market might be in Business as Usual in UK Pension Risk Transfer Market Amid Record Low Mortality in England and Wales.

A new report by reinsurer RGA says that the combination of disease-modifying therapies and better understanding of the causes and progression of Alzheimer’s “point to a future that is cautiously but meaningfully brighter”. Mark McCord spoke to Richard Russell, Vice President, Biometric Research, Global R&D at RGA to find out how actuaries see the current state of play in Better Understanding of Alzheimer’s is Improving Lives if Not Actuarial Assumptions – Yet. 

A new consultation paper from the European Insurance and Occupational Pensions Authority (EIOPA) provides insights into the regulator’s current view on the ‘private equity ownership of insurance companies’ zeitgeist. Greg Winterton spoke to Luca Tres, Head of Strategic Risk and Capital Life Solutions, EMEA at Guy Carpenter, to get his thoughts on the topics highlighted in the document in EIOPA Sets Out Views on Private Equity Ownership of Life Insurers in New Consultation Paper. 

The dominant approach to modelling impaired mortality in life settlements is the constant mortality multiplier, which, while offering simplicity, has drawbacks. That’s according to Liam Bodemeaid, Founder & Principal Actuarial Consultant at Paragon Longevity Analytics, who explains why, and offers an alternative approach, in Better Mortality Analytics Will Unlock the Next Phase of Life Settlement Growth, a guest article. 

The life settlement’s secondary market sees significant deal flow from advisors such as attorneys, CPAs and financial planners. Greg Winterton caught up with Brandon Marz, Co-Founder and Chief Strategy Officer at LifeRoc Capital, to get his thoughts on the ‘state of the market’ for this cohort as it pertains to life settlements in this month’s Q&A. 

Despite UK law giving life insurance policyholders the right to sell their policy to a third party, the country has no discernible secondary market for life insurance. Greg Winterton spoke to Devam Sukhija, CEO and Founder of Pembridge Life, to learn about why a different approach might be required in order to kick-start activity in the space in Is the Secondary Life Insurance Market in the UK Set To Re-Emerge? 

We hope you enjoy the latest issue of Longevity and Mortality Investor.